Abstract Treatment with amiodarone is associated with changes in thyroid function tests, but
also with thyroid dysfunction (amiodarone-induced hypothyroidism, AIH, and amiodarone …

Amiodarone-induced thyroid dysfunction occurs in 15–20% of amiodarone-treated patients.
Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily …

Summary Objective To investigate how North American thyroidologists assess and treat
amiodarone‐induced thyrotoxicosis (AIT) and to compare the results with those of the same …

Assessment of TSH and TPO-Ab before starting amiodarone (AM) treatment is
recommended. The usefulness of periodic TSH measurement every 6 months during AM …

Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a
structure similar to that of thyroid hormones. Deiodination of amiodarone releases large …

Summary objective To determine how expert European thyroidologists assess and treat
amiodarone‐induced thyrotoxicosis (AIT). design Members of the European Thyroid …

Objective Amiodarone is frequently associated with thyroid dysfunction. Identifying
predictors for amiodarone‐associated thyroid dysfunction and assessing treatment outcome …

Amiodarone is a highly eVective agent for the prophylaxis and treatment of many cardiac
rhythm disturbances, ranging from paroxysmal atrial fibrillation to life threatening ventricular …

Background Amiodarone-induced thyrotoxicosis (AIT) develops in 3% of amiodarone-
treated patients in North America. AIT is classified as type 1 or type 2. Type 1 AIT occurs in …

Amiodarone is an effective medication for the treatment of cardiac arrhythmias. Originally
developed for the treatment of angina, it is now the most frequently prescribed …